Mono-dosed sustained release medicaments (tablets) stop at certain sites irritating the mucosa: the release can be reduced and medicaments not fully absorbed.
Osmopharm's 1-1,2 mm sized spherical pellet granules assure a rapid and homogeneous spread of the medicament in the gastrointestinal tract avoiding those risks.
Osmopharm is a Swiss pharmaceutical Company. Created in 1994, it is specialised in modified release systems for oral drugs, based on the application of some of the more advanced galenic technologies.
Osmopharm is located in Southern Switzerland, a few km north of Lugano and 70 km from Milan.The total covered surface, exterior warehouses comprised, is about 6.000 sqm.
Our product list consist of the pharmaceuticals, pharmaceutical associations and food in the dosages and forms most required by our customers.
